Abstract

The popularity of personalized drug therapy in neurology is becoming more and more widespread. With the continuous development of drug monitoring and genomics, personalized therapy model has been applied to a variety of diseases. Drug monitoring refers to the detection of blood drug concentration of patients during medication, so as to adjust the medication regimen in real time. Genomics refers to the study of genetic polymorphisms in patients, including abnormalities in the function of drug-metabolizing enzymes, drug transport, and drug targets. According to the relevant reports at home and abroad, the application of the main personalized treatment methods, namely drug monitoring and genomics, in the field of neurology was summarized. The challenges and prospects of personalized medicine in the field of neurology were put forward, so as to provide better ideas for the optimization of individualized treatment in the follow-up clinical treatment.